Results 91 to 100 of about 7,708 (214)
Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study
Atherothrombosis is a multifactorial process, governed by an interaction between the vessel wall, hemodynamic factors and systemic atherothrombotic risk factors.
Suzanne Battjes +22 more
core +1 more source
Differentiated thyroid cancer in patients with prolactinoma
© TÜBİTAK.Background/aim: Increasing evidence is available about the role of prolactin in the development of various cancers. The purpose of this study is to evaluate the frequency of thyroid cancer in patients with prolactinoma followed at a single site.
Tam, ABBAS ALİ +4 more
core +1 more source
Plasma Leptin Levels Before and After Bromocriptine Treatment in Female Patients with Prolactinoma
Both It is known that increased body weight is associated with prolactinomas. However, effects of bromocriptine treatment on plasma leptin levels is not clear yet.
Metin Özata +2 more
doaj
YouTube and Prolactinoma: Assessing the Impact on Patient Knowledge [PDF]
Purpose With the increasing access to the internet worldwide, In medicine, patients have been using this tool to look for treatment for some medical topics.
Garzón Molina, Claudia Ximena +5 more
core
Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients.
Prolactinoma is the most frequent pituitary tumour among women of child-bearing age. Only a few studies have addressed the outcome of prolactinoma after pregnancy.JOURNAL ARTICLESCOPUS: ar.jFLWINinfo:eu-repo/semantics ...
Devuyst, France +4 more
core +1 more source
Transcriptomic analysis of the anti-tumor effects of leflunomide in prolactinoma
Leflunomide’s anti-tumor effects have been investigated in various types of tumors; however, its impact on pituitary adenoma, particularly prolactinoma, is unclear.
Xiangdong Pei +6 more
doaj +1 more source
Modern approach to bone comorbidity in prolactinoma
Prolactinomas account for more than half of pituitary adenomas, and besides their clinical impact on fertility and gonadal function, they lead to detrimental effects on bone.
Menotti, Sara +3 more
core +1 more source
A case of rapidly increasing cabergoline-resistant male prolactinoma
Cabergoline, a dopamine agonist, is the first-line drug for treating prolactinoma. However, some rare cases exhibit resistance to cabergoline. Here, we report a rare case of prolactinoma in a male patient that recurred in a short period while the patient
Toshiya Ichinose +2 more
doaj +1 more source
Introduction: Prolactinomas can induce castrate-level testosterone suppression by dysregulating the hypothalamic-pituitary-gonadal axis. While hypogonadism typically confers a reduced risk for prostate cancer (PCa), malignancy can still occur ...
Tara A. Seibert +2 more
doaj +1 more source

